Monoclonal antibody treatment is used to treat people with mild-to-moderate COVID-19 who may be at high risk of developing more severe symptoms. Monoclonal antibodies are similar to the antibodies your body makes to help fight infection. People with COVID-19 who have a single treatment of monoclonal antibodies have fewer symptoms and go to the hospital less than those who don’t receive the treatment.
Comments
0 comments
Article is closed for comments.